Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 SEK | +11.11% | +20.19% | -97.50% |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
05-16 | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
32.07M | - | |||||
62.59B | - | |||||
41.18B | ||||||
40.29B | ||||||
27.9B | ||||||
26.21B |